Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma

Published:2017-01 Issue:1 Volume:3 Page:49-52
ISSN:2475-3246
Container-title:Journal of Pancreatic Cancer
language:en
Short-container-title:Journal of Pancreatic Cancer

Author:

So Eiichiro¹,Crees Zachary D.²,Crites Danielle³,Wang-Gillam Andrea³

Affiliation:

1. Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

2. Department of Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri.

3. Division of Hematology and Oncology, Department of Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, Missouri.

Publisher

Mary Ann Liebert Inc

Link

http://www.liebertpub.com/doi/pdf/10.1089/pancan.2017.0012

Reference12 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

2. Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials

3. Gemcitabine: vascular toxicity and prothrombotic potential

4. Digital ischemic events related to gemcitabine: Report of two cases and a systematic review

5. A Case of Progressive Digital Ischemia after Early Withdrawal of Gemcitabine and S-1 in a Patient with Systemic Sclerosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic safety profile of pancreatic cancer‑bearing mice fed a ketogenic diet in combination with gemcitabine;Oncology Letters;2023-09-22

2. Gemcitabine-induced digital ischaemia in a patient with metastatic breast cancer;BMJ Case Reports;2022-11

3. Progressive digital necrosis during gemcitabine/nab‐paclitaxel chemotherapy in a patient with pancreatic cancer;Dermatologic Therapy;2022-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3